-
Mashup Score: 7
177Lutetium-labeled radiohybrid Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1), Combination of MEK inhibitor cobimetinib with 177Lu-rhPSMA-10.1 radioligand therapy, American Association for Cancer Research (AACR) Annual Meeting 2024.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2An International Multi-Institutional Validation Study of the Algorithm for Prostate Cancer Detection and Gleason Grading - Beyond the Abstract - 1 month(s) ago
HALO Prostate AI, prostate cancer, Diagnosing prostate cancer, HALO AP digital pathology, Gleason Grading, Prostate Cancer Detection and Gleason Grading, prostate core needle biopsies.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
prostate cancer, ligand-receptor pairs Bgn-Tlr2, Spp1-Cd44, and Hgf-Met, Akt/mTOR pathways, MNK/eIF4E Pathways, tumor suppressor PDCD4, eFT508, ipatasertib, Myeloid-Derived Suppressor Cells (MDSC), T cell inhibitors.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer – Beyond the Abstract - 2 month(s) ago
BAG-1L, BAG-1M, BAG-1S, androgen receptor (AR), advanced castration-sensitive prostate cancer (CSPC), castration-resistant prostate cancer (CRPC), AR-targeting therapy, docetaxel chemotherapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer – Beyond the Abstract - 3 month(s) ago
BAG-1L, BAG-1M, BAG-1S, androgen receptor (AR), advanced castration-sensitive prostate cancer (CSPC), castration-resistant prostate cancer (CRPC), AR-targeting therapy, docetaxel chemotherapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
prostate cancer, ligand-receptor pairs Bgn-Tlr2, Spp1-Cd44, and Hgf-Met, Akt/mTOR pathways, MNK/eIF4E Pathways, tumor suppressor PDCD4, eFT508, ipatasertib, Myeloid-Derived Suppressor Cells (MDSC), T cell inhibitors.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer – Beyond the Abstract - 4 month(s) ago
BAG-1L, BAG-1M, BAG-1S, androgen receptor (AR), advanced castration-sensitive prostate cancer (CSPC), castration-resistant prostate cancer (CRPC), AR-targeting therapy, docetaxel chemotherapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
prostate cancer, ligand-receptor pairs Bgn-Tlr2, Spp1-Cd44, and Hgf-Met, Akt/mTOR pathways, MNK/eIF4E Pathways, tumor suppressor PDCD4, eFT508, ipatasertib, Myeloid-Derived Suppressor Cells (MDSC), T cell inhibitors.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Blue Earth Therapeutics announces promising results from preclinical evaluation of synergistic drug combinations with radiopharmaceutical 177Lu-rhPSMA-10.1 for the treatment of #ProstateCancer. #ReadNow details on UroToday > https://t.co/3onhsYaQ8V @gaudend @AACR https://t.co/rxXLWahAdL